Effects of GLP-1 Agonists on mortality and arrhythmias in patients with Type II diabetes.

Al-Sadawi, Mohammed A; Aslam, Faisal M; Tao, Michael; Alsaiqali, Mahmoud; Almasry, Ibrahim O; Fan, Roger; Rashba, Eric J; Singh, Abhijeet

Al-Sadawi, Mohammed A; Aslam, Faisal M; Tao, Michael; Alsaiqali, Mahmoud; Almasry, Ibrahim O; Fan, Roger; Rashba, Eric J; Singh, Abhijeet.

Afiliación

Al-Sadawi MA; Cardiovascular Department, Stony Brook Medicine, Stony Brook, NY, USA.
Aslam FM; Cardiovascular Department, Stony Brook Medicine, Stony Brook, NY, USA.
Tao M; Cardiovascular Department, Stony Brook Medicine, Stony Brook, NY, USA.
Alsaiqali M; Department of Medicine, SUNY Downstate, Brooklyn, NY, USA.
Almasry IO; Cardiovascular Department, Stony Brook Medicine, Stony Brook, NY, USA.
Fan R; Cardiovascular Department, Stony Brook Medicine, Stony Brook, NY, USA.
Rashba EJ; Cardiovascular Department, Stony Brook Medicine, Stony Brook, NY, USA.
Singh A; Cardiovascular Department, Stony Brook Medicine, Stony Brook, NY, USA.

Int J Cardiol Heart Vasc ; 47: 101218, 2023 Aug.

Article en En | MEDLINE | ID: mdl-37252197

Palabras clave

Arrhythmias; GLP-1 agonists; Mortality; Outcomes; Sudden cardiac death

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Clinical_trials Idioma: En Revista: Int J Cardiol Heart Vasc Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Irlanda

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google